Cargando…
Sleep Apnea and Fetal Growth Restriction (SAFER) study: protocol for a pragmatic randomised clinical trial of positive airway pressure as an antenatal therapy for fetal growth restriction in maternal obstructive sleep apnoea
INTRODUCTION: Fetal growth restriction (FGR) is a major contributor to fetal and neonatal morbidity and mortality with intrauterine, neonatal and lifelong complications. This study explores maternal obstructive sleep apnoea (OSA) as a potentially modifiable risk factor for FGR. We hypothesise that,...
Autores principales: | Hincker, Alex, Nadler, Jacob, Karan, Suzanne, Carter, Ebony, Porat, Shay, Warner, Barbara, Ju, Yo-El S, Ben Abdallah, Arbi, Wilson, Elizabeth, Lockhart, Ellen M, Ginosar, Yehuda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245445/ https://www.ncbi.nlm.nih.gov/pubmed/34187829 http://dx.doi.org/10.1136/bmjopen-2021-049120 |
Ejemplares similares
-
Metabolomics for predicting fetal growth restriction: protocol for a systematic review and meta-analysis
por: Leite, Debora Farias Batista, et al.
Publicado: (2018) -
Prediction of late-onset fetal growth restriction by umbilical artery velocities at 37 weeks of gestation: a cross-sectional study
por: Liu, Hongli, et al.
Publicado: (2022) -
Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction—a phase I pilot clinical trial: study protocol
por: Alers, Nicole O, et al.
Publicado: (2013) -
TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial
por: Umekawa, Takashi, et al.
Publicado: (2018) -
Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction
por: Palmer, Kirsten R, et al.
Publicado: (2019)